Cited by 368Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 46 of the 51 references it cites were found in a registry or an index, and 5 are not checked yet.

The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation

Open access

Meyers, Shari, Lenny, Noel, Hiebert, Scott W.·1995·Molecular and Cellular Biology

DOI 10.1128/mcb.15.4.1974PMC PMC230424

Open this paper in CoChat — free account

Abstract

The AML-1/CBF beta transcription factor complex is targeted by both the t(8;21) and the inv(16) chromosomal alterations, which are frequently observed in acute myelogenous leukemia. AML-1 is a site-specific DNA-binding protein that recognizes the enhancer core motif TGTGGT. The t(8;21) translocation fuses the first 177 amino acids of AML-1 to MTG8 (also known as ETO), generating a chimeric protein that retains the DNA-binding domain of AML-1. Analysis of endogenous AML-1 DNA-binding complexes suggested the presence of at least two AML-1 isoforms. Accordingly, we screened a human B-cell cDNA library and isolated a larger, potentially alternatively spliced, form of AML1, termed AML1B. AML-1B is a protein of 53 kDa that binds to a consensus AML-1-binding site and complexes with CBF beta. Subcellular fractionation experiments demonstrated that both AML-1 and AML-1/ETO are efficiently extracted from the nucleus under ionic conditions but that AML-1B is localized to a salt-resistant nuclear compartment. Analysis of the transcriptional activities of AML-1, AML-1B, and AML-1/ETO demonstrated that only AML-1B activates transcription from the T-cell receptor beta enhancer. Mixing experiments indicated that AML-1/ETO can efficiently block AML-1B-dependent transcriptional activation, suggesting that the t(8;21) translocation creates a dominant interfering protein.

Integrity signals

Registry

Crossref · 10.1128/mcb.15.4.1974

Cites

46 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.229 · Cited by 3,485
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Multiple Point Mutations Affecting the Simian Virus 40 Enhancer
Weiher, H., König, M., & Gruß, P. (1983) · Science · doi:10.1126/science.6297005 · Cited by 803
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells
Berger, J., Hauber, J., Hauber, R., Geiger, R. E., & Cullen, B. R. (1988) · Gene · doi:10.1016/0378-1119(88)90219-3 · Cited by 667
Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene.
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.Preprint
Hiebert, S. W., Chellappan, S., Horowitz, J. M., & Nevins, J. R. (1992) · Genes & Development · doi:10.1101/gad.6.2.177 · Cited by 576
Self-citation

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 5

Bae S.-C., 1994, Mol. Cell. Biol., 14, 3242
Bae S. C., 1993, Oncogene, 8, 809
Gottschalk L. R., 1990, Mol. Cell. Biol., 10, 5486
Redondo J. M., 1991, Mol. Cell. Biol., 11, 5671
Wang S., 1993, EMBO J., 13, 3324

Sorted by citations

Items 101–200 of 367

The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFα2 transcription factor
McNeil, S. M., Zeng, C., Harrington, K. S., Hiebert, S. W., Lian, J. B., Stein, J. L., van Wijnen, A. J., & Stein, G. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14882 · Cited by 97
Self-citation
Core Binding Factor Cannot Synergistically Activate the Myeloperoxidase Proximal Enhancer in Immature Myeloid Cells without c-Myb
Britos-Bray, M., & Friedman, A. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5127 · Cited by 94
A Large Variety of Alternatively Spliced and Differentially Expressed mRNAs Are Encoded by the Human Acute Myeloid Leukemia Gene AML1
Levanon, D., Bernstein, Y., Negreanu, V., Ghozi, M. C., Bar‐Am, I., Aloya, R. B.-A., Goldenberg, D., Lotem, J., & Groner, Y. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.175 · Cited by 94
The RUNX1–PU.1 axis in the control of hematopoiesis
Imperato, M. R., Cauchy, P., Obier, N., & Bonifer, C. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1762-8 · Cited by 94
The core-binding factor leukemias: lessons learned from murine models
Downing, J. R. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00018-7 · Cited by 95
Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue, T., Tamura, T., & Ozato, K. (2001) · International Reviews of Immunology · doi:10.3109/08830180109056724 · Cited by 94
Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b(ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF
Shimada, H., Ichikawa, H., Nakamura, S., Katsu, R., Iwasa, M., Kitabayashi, I., & Ohki, M. (2000) · Blood · doi:10.1182/blood.v96.2.655 · Cited by 93
Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo, Y.-H., Zaidi, S. K., Gornostaeva, S., Komori, T., Stein, G., & Castilla, L. (2009) · Blood · doi:10.1182/blood-2008-06-162248 · Cited by 95
Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
Reilly, J. T. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05236.x · Cited by 90
Expression and Function of a Stem Cell Promoter for the Murine CBFα2 Gene: Distinct Roles and Regulation in Natural Killer and T Cell Development
Telfer, J. C., & Rothenberg, E. V. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9991 · Cited by 89
p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death
Krejci, O., Wunderlich, M., Geiger, H., Chou, F., Schleimer, D., Jansen, M., Andreassen, P. R., & Mulloy, J. C. (2007) · Blood · doi:10.1182/blood-2007-06-093682 · Cited by 90
Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML
Deguchi, K., & Gilliland, D. G. (2002) · Leukemia · doi:10.1038/sj.leu.2402500 · Cited by 90
Complex regulation of acetylcholinesterase gene expression in human brain tumors
Perry, C., Sklan, E. H., Birikh, K. R., Shapira, M., Trejo, L., Eldor, A., & Soreq, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205945 · Cited by 89
Activated Ca2+/Calmodulin-Dependent Protein Kinase IIγ Is a Critical Regulator of Myeloid Leukemia Cell Proliferation
Si, J., & Collins, S. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2509 · Cited by 88
Core binding factor genes and human leukemia.
Hart, S., & Foroni, L. (2002) · PubMed · Cited by 88
A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with MYC
Vaillant, F., Blyth, K., Terry, A., Bell, M., Cameron, E. R., Neil, J. C., & Stewart, M. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203202 · Cited by 87
AML1/RUNX1 Increases During G1 to S Cell Cycle Progression Independent of Cytokine-dependent Phosphorylation and Induces Cyclin D3 Gene Expression
Bernardin, F., Kummalue, T., Leijen, S., Collector, M. I., Ravid, K., & Friedman, A. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310023200 · Cited by 86
Ras Signaling Enhances the Activity of C/EBPα to Induce Granulocytic Differentiation by Phosphorylation of Serine 248
Behre, G., Singh, S. M., Liu, H., Bortolin, L. T., Christopeit, M., Radomska, H. S., Rangatia, J., Hiddemann, W., Friedman, A. D., & Tenen, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202301200 · Cited by 82
Cell differentiation in acute myeloid leukemia
Olsson, I., Bergh, G., Ehinger, M., & Gullberg, U. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb00483.x · Cited by 85
Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear -2, a mammalian homolog of Drosophila seven-up , and a chimeric leukemogenic gene, AML1/ETO ( MTG8 )
Ahn, M., Huang, G., Bae, S., Wee, H., Kim, W., & Ito, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1812 · Cited by 84
Common themes in the pathogenesis of acute myeloid leukemia
Alcalay, M., Orleth, A., Sebastiani, C., Meani, N., Chiaradonna, F., Casciari, C., Sciurpi, M. T., Gelmetti, V., Riganelli, D., Minucci, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204642 · Cited by 87
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
Larizza, L., Magnani, I., & Beghini, A. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400007565 · Cited by 82
The molecular pathogenesis of acute myeloid leukemia
Steffen, B., Müller‐Tidow, C., Schwäble, J., Berdel, W. E., & Serve, H. L. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.10.012 · Cited by 85
Cytoplasmic Sequestration of the Polyomavirus Enhancer Binding Protein 2 (PEBP2)/Core Binding Factor α (CBFα) Subunit by the Leukemia-Related PEBP2/CBFβ-SMMHC Fusion Protein Inhibits PEBP2/CBF-Mediated Transactivation
Kanno, Y., Kanno, T., Sakakura, C., Bae, S., & Ito, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4252 · Cited by 81
Association of CBFA2 mutation with decreased platelet PKC-θ and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation
Sun, L., Mao, G., & Rao, A. K. (2004) · Blood · doi:10.1182/blood-2003-07-2299 · Cited by 79
Links Among Growth Factors, Hormones, and Nuclear Factors With Essential Roles in Bone Formation
McCarthy, T. L., & Ji, C. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110040201 · Cited by 77
A Novel Transcript Encoding an N-Terminally Truncated AML1/PEBP2αB Protein Interferes with Transactivation and Blocks Granulocytic Differentiation of 32Dcl3 Myeloid Cells
Zhang, Y.-W., Bae, S.-C., Huang, G., Fu, Y.-X., Lu, J., Ahn, M.-Y., Kanno, Y., Kanno, T., & Ito, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4133 · Cited by 77
Runx2 regulates survivin expression in prostate cancer cells
Lim, M. A., Zhong, C., Yang, S., Bell, A. M., Cohen, M. B., & Roy‐Burman, P. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.128 · Cited by 75
The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications
Asou, N. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00003-3 · Cited by 75
MicroRNA‐27 enhances differentiation of myeloblasts into granulocytes by post‐transcriptionally downregulating Runx1
Feng, J., Iwama, A., Satake, M., & Kohu, K. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07632.x · Cited by 75
AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches
Hatlen, M. A., Wang, L., & Nimer, S. D. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0206-6 · Cited by 74
Transcriptional regulation during myelopoiesis
Lenny, N. T., Westendorf, J. J., & Hiebert, S. W. (1997) · Molecular Biology Reports · doi:10.1023/a:1006859700409 · Cited by 73
Self-citation
AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
Gardini, A., Cesaroni, M., Luzi, L., Okumura, A. J., Biggs, J. R., Minardi, S. P., Venturini, E., Zhang, D., Pelicci, P. G., & Alcalay, M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000275 · Cited by 72
Molecular Genetics of Childhood Leukemias
Rubnitz, J. E., & Look, A. T. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199801000-00001 · Cited by 69
Normal and transforming functions of RUNX1: A perspective
Mikhail, F. M., Sinha, K. K., Saunthararajah, Y., & Nucifora, G. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20538 · Cited by 68
The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs
Mandoli, A., Singh, A. A., Prange, K. H. M., Tijchon, E. J. H., Oerlemans, M. M. P., Dirks, R. A. M., ter Huurne, M., Wierenga, A. T. J., Janssen‐Megens, E. M., Berentsen, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.082 · Cited by 64
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34 + cells, allowing nerve growth factor-induced expansion
Mulloy, J. C., Jankovic, V. S., Wunderlich, M., Delwel, R., Cammenga, J., Krejci, O., Zhao, H., Valk, P. J. M., Löwenberg, B., & Nimer, S. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404701102 · Cited by 68
Mtgr1 Is a Transcriptional Corepressor That Is Required for Maintenance of the Secretory Cell Lineage in the Small Intestine
Amann, J. M., Chyla, B., Ellis, T. C., Martinez, A., Moore, A. C., Franklin, J. L., McGhee, L., Meyers, S., Ohm, J. E., Luce, K. S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9576-9585.2005 · Cited by 65
Self-citation
AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein
Melnick, A. M., Carlile, G. W., McConnell, M. J., Polinger, A., Hiebert, S. W., & Licht, J. D. (2000) · Blood · doi:10.1182/blood.v96.12.3939 · Cited by 66
Self-citation
Biological Characteristics of the Leukemia-Associated Transcriptional Factor AML1 Disclosed by Hematopoietic Rescue of AML1 -Deficient Embryonic Stem Cells by Using a Knock-in Strategy
Okuda, T., Takeda, K., Fujita, Y., Nishimura, M., Yagyu, S., Yoshida, M., Akira, S., Downing, J. R., & Abe, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.319-328.2000 · Cited by 67
Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ
Bristow, C. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg401 · Cited by 71
Impaired cell cycle regulation of the osteoblast‐related heterodimeric transcription factor Runx2‐Cbfβ in osteosarcoma cells
Martin, I. A. S., Varela, N., Gaete, M., Villegas, K., Osorio, M., Tapia, J. C., Antonelli, M., Mancilla, E. E., Pereira, B. P., Nathan, S. S., et al. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21894 · Cited by 63
Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins
Barseguian, K., Lutterbach, B. A., Hiebert, S. W., Nickerson, J. A., Lian, J. B., Stein, J. L., van Wijnen, A. J., & Stein, G. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242588499 · Cited by 62
Self-citation
Diagnostic Complexities of Eosinophilia
Montgomery, N. D., Dunphy, C. H., Mooberry, M. J., Laramore, A., Foster, M. C., Park, S. I., & Fedoriw, Y. D. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0597-ra · Cited by 59
Alterations of the AML1 transcription factor in human leukemia
Downing, J. R., Higuchi, M., Lenny, N. T., & Yeoh, A. E. J. (2000) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0183 · Cited by 59
Self-citation
Epigenetic consequences of AML1–ETO action at the human c‐FMS locus
Follows, G., Tagoh, H., Lefevre, P., Hodge, D., Morgan, G. J., & Bonifer, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg250 · Cited by 60
RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53
Wotton, S., Blyth, K., Kilbey, A., Jenkins, A., Terry, A., Bernardin, F., Friedman, A. D., Baxter, E. W., Neil, J. C., & Cameron, E. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207729 · Cited by 58
Identification of an Alternatively Spliced Form of the Mouse AML1/RUNX1 Gene Transcript AML1c and Its Expression in Early Hematopoietic Development
Fujita, Y., Nishimura, M., Taniwaki, M., Abe, T., & Okuda, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4513 · Cited by 58
Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production
Geddis, A. E., & Kaushansky, K. (2004) · Current Opinion in Pediatrics · doi:10.1097/00008480-200402000-00005 · Cited by 58
The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells
Tonks, A., Pearn, L., Tonks, A. J., Pearce, L., Hoy, T. G., Phillips, S., Fisher, J., Downing, J. R., Burnett, A. K., & Darley, R. L. (2002) · Blood · doi:10.1182/blood-2002-06-1732 · Cited by 58
Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7
Langabeer, S. E., Gale, R. E., Rollinson, S. J., Morgan, G. J., & Linch, D. C. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10031 · Cited by 57
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype
Matsuno, N., Osato, M., Yamashita, N., Yanagida, M., Nanri, T., Fukushima, T., Motoji, T., KUSUMOTO, S., Towatari, M., Suzuki, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403160 · Cited by 57
CBFβ is critical for AML1-ETO and TEL-AML1 activity
Roudaia, L., Cheney, M. D., Manuylova, E., Chen, W., Morrow, M., Park, S., Lee, C.-T., Kaur, P., Williams, O., Bushweller, J. H., et al. (2009) · Blood · doi:10.1182/blood-2008-03-147207 · Cited by 55
Structural and Functional Characterization of the Human CD36 Gene Promoter
Armesilla, A. L., Calvo, D., & Vega, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7781 · Cited by 55
VWRPY motif–dependent and –independent roles of AML1/Runx1 transcription factor in murine hematopoietic development
Nishimura, M., Fukushima‐Nakase, Y., Fujita, Y., Nakao, M., Toda, S., Kitamura, N., Abe, T., & Okuda, T. (2003) · Blood · doi:10.1182/blood-2003-06-2109 · Cited by 57
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells
Nimer, S. D., & Moore, M. A. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207673 · Cited by 55
The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1
Frank, R. C., Sun, X., Berguido, F. J., Jakubowiak, A. J., & Nimer, S. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202459 · Cited by 56
Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor α-Dependent Signaling Pathway
Le, X., Groner, Y., Kornblau, S. M., Gu, Y., Hittelman, W. N., Levanon, D., Mehta, K., Arlinghaus, R. B., & Chang, K.-S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21651 · Cited by 56
Exogenous cdk4 overcomes reducedcdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF – a model for overcoming inhibition of proliferation by CBF oncoproteins
Lou, J., Cao, W., Bernardin, F., Ayyanathan, K., Rauscher, F. J., & Friedman, A. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203588 · Cited by 56
The phosphorylation state of an autoregulatory domain controls PACS‐1‐directed protein traffic
Scott, G. K., Gu, F., Crump, C. M., Thomas, L., Wan, L., Xiang, Y. K., & Thomas, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg596 · Cited by 52
The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages
Himes, S. R., Cronau, S. L., Mulford, C., & Hume, D. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208657 · Cited by 53
Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter
Uchida, H., Downing, J. R., Miyazaki, Y., Frank, R. C., Zhang, J., & Nimer, S. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202383 · Cited by 55
Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis
Liu, X.-T., Zhang, Q., Zhang, D.-E., Zhou, C., Xing, H., Tian, Z., Rao, Q., Wang, M., & Wang, J. (2008) · Leukemia · doi:10.1038/leu.2008.350 · Cited by 53
Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia
Li, Y., Wang, H., Wang, X., Jin, W. Y., Tan, Y., Fang, H., Chen, S., Zhu, C. H., & Wang, K. (2015) · Blood · doi:10.1182/blood-2015-03-626671 · Cited by 50
Identification and characterization of a protein containing formin homology (FH1/FH2) domains
Westendorf, J. J., Mernaugh, R. L., & Hiebert, S. W. (1999) · Gene · doi:10.1016/s0378-1119(99)00127-4 · Cited by 52
Self-citation
Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation
Ritter, M., Thiede, C., Schäkel, U., Schmidt, M., Alpen, B., Pascheberg, U., Mohr, B., Ehninger, G., Neubauer, A., & for the AML‐SHG study group (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2933107.x · Cited by 52
RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements.
Puig-Kröger, A., Sánchez-Elsner, T., Ruiz, N., Andreu, E. J., Prosper, F., Jensen, U. B., Gil, J., Erickson, P., Drabkin, H., Groner, Y., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0618 · Cited by 51
An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis
Doll, A., González, M., Abal, M., Llauradó, M., Rigau, M., Colás, E., Monge, M., Xercavins, J., Capellá, G., Díaz‐Feijoó, B., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24330 · Cited by 51
Oct-1 Counteracts Autoinhibition of Runx2 DNA Binding To Form a Novel Runx2/Oct-1 Complex on the Promoter of the Mammary Gland-Specific Gene β- casein
Inman, C. K., Li, N., & Shore, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3182-3193.2005 · Cited by 53
Runx1/AML1 in leukemia: disrupted association with diverse protein partners
Perry, C., Eldor, A., & Soreq, H. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00128-x · Cited by 51
Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb
Zaiman, A., & Lenz, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5618-5629.1996 · Cited by 50
Regulation of GM-CSF gene transcription by core-binding factor.
Cockerill, P. N., Osborne, C. S., Bert, A. G., & Grotto, R. J. (1996) · PubMed · Cited by 50
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from thePSA upstream regulatory region
Fowler, M., Borazanci, E. H., McGhee, L., Pylant, S. W., Williams, B. J., Glass, J., Davis, J. N., & Meyers, S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20664 · Cited by 49
Self-citation
AML3/CBFα1 Is Required for Androgen-specific Activation of the Enhancer of the Mouse Sex-limited Protein (Slp) Gene
Ning, Y.-M., & Robins, D. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30624 · Cited by 48
The AML1/ETO(MTG8) and AML1/Evi-1 Leukemia-Associated Chimeric Oncoproteins Accumulate PEBP2β(CBFβ) in the Nucleus More Efficiently Than Wild-Type AML1
Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y., & Hirai, H. (1998) · Blood · doi:10.1182/blood.v91.5.1688 · Cited by 48
Molecular characterization of genomic AML1-ETO fusions in childhood leukemia
Xiao, Z., Greaves, M. F., Buffler, P. A., Smith, M., Segal, M. R., Dicks, B., Wiencke, J. K., & Wiemels, J. (2001) · Leukemia · doi:10.1038/sj.leu.2402318 · Cited by 48
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
Zent, C. S., Mathieu, C., Claxton, D. F., Zhang, D., Tenen, D. G., Rowley, J. D., & Nucifora, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1044 · Cited by 48
CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity
Kozlov, I., Beason, K. L., Yu, C. L., & Hughson, M. D. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.06.002 · Cited by 45
ETO-2, a new member of the ETO-family of nuclear proteins
Davis, J. N., Williams, B. J., Herron, J. T., Galiano, F. J., & Meyers, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202412 · Cited by 47
Self-citation
Induction of interferon-γ production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation
Yang, J., Murphy, T. L., Ouyang, W., & MURPHY, K. M. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02 · Cited by 195
Molecular genetics of acute leukaemia
Sawyers, C. L. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07535-6 · Cited by 45
Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)
Vivacqua, A., Marco, P. D., Santolla, M. F., Cirillo, F., PELLEGRINO, M. A., Panno, M. L., Abonante, S., & Maggiolini, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4117 · Cited by 46
AML1 stimulates G1 to S progression via its transactivation domain
Bernardin, F., & Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205447 · Cited by 46
The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor
Wildonger, J., & Mann, R. S. (2005) · Development · doi:10.1242/dev.01824 · Cited by 48
Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases
Graessle, S., Loidl, P., & Brosch, G. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000894 · Cited by 46
Cloning and embryonic expression patterns of the zebrafish Runt domain genes, runxa and runxb
Kataoka, H. C., Ochi, M., Enomoto, K., & Yamaguchi, A. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00445-7 · Cited by 45
Insulin-stimulated cell growth in insulin receptor substrate-1–deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase–independent pathway
Gliozzo, B., Sung, C. K., Scalia, P., Papa, V., Frasca, F., Sciacca, L., Giorgino, F., Milazzo, G., Goldfine, I. D., Vigneri, R., et al. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980801)70:2 · Cited by 27
RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress
Wolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E. R., & Neil, J. C. (2009) · Oncogene · doi:10.1038/onc.2009.101 · Cited by 45
A New Cellular Factor Recognizes E2 Binding Sites of Papillomaviruses Which Mediate Transcriptional Repression by E2
Boeckle, S., Pfister, H., & Steger, G. (2002) · Virology · doi:10.1006/viro.2001.1231 · Cited by 44
The Core Binding Factor (CBF) α Interaction Domain and the Smooth Muscle Myosin Heavy Chain (SMMHC) Segment of CBFβ-SMMHC Are Both Required to Slow Cell Proliferation
Cao, W., Adya, N., Britos-Bray, M. F., Liu, P., & Friedman, A. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31534 · Cited by 43
Physical and functional link of the leukemia-associated factors AML1 and PML
Nguyen, L. A., Pandolfi, P. P., Aikawa, Y., Tagata, Y., Ohki, M., & Kitabayashi, I. (2004) · Blood · doi:10.1182/blood-2004-03-1185 · Cited by 42
TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL
Morrow, M., Samanta, A., Kioussis, D., Brady, H. J. M., & Williams, O. (2007) · Oncogene · doi:10.1038/sj.onc.1210227 · Cited by 42
CBFβ-SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces p53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-Damaging Agents
Britos-Bray, M. F., Ramírez, M. R., Cao, W., Wang, X., Liu, P. P., Civin, C. I., & Friedman, A. D. (1998) · Blood · doi:10.1182/blood.v92.11.4344 · Cited by 41
The Runt Domain Transcription Factor, PEBP2/CBF, and its Involvement in Human Leukemia
Ito, Y., & Bae, S. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_4 · Cited by 40
Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cells
Liu, Y.-N., Kang, B.-B., & Chen, J. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207022 · Cited by 39
Transcriptional regulation of hemopoiesis
Barreda, D. R., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00035-0 · Cited by 40
Analysis of the Modulation of Transcriptional Activity in Myelopoiesis and Leukemogenesis
Behre, G., Zhang, P., Zhang, D., & Tenen, D. G. (1999) · Methods · doi:10.1006/meth.1998.0733 · Cited by 41
Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions
Brendel, C. A., & Neubauer, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401907 · Cited by 39
Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B
Itonaga, H., Imanishi, D., Wong, Y.-F., Sato, S., Ando, K., Sawayama, Y., Sasaki, D., Tsuruda, K., Hasegawa, H., Imaizumi, Y., et al. (2014) · Leukemia · doi:10.1038/leu.2014.15 · Cited by 38
Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins
Sykes, D. B., & Kamps, M. P. (2001) · Blood · doi:10.1182/blood.v98.8.2308 · Cited by 38

Authors: Meyers, S., Lenny, N., & Hiebert, S. W.
Affiliations: St. Jude Children's Research Hospital (US)
ORCID: Hiebert, Scott W.
Venue: Molecular and Cellular Biology
Publisher: Informa UK Limited
Published: 1995-04-01
Volume: 15
Issue: 4
Pages: 1974-1982
ISSN: 0270-7306 (ISSN-L)
1098-5549
DOI: 10.1128/mcb.15.4.1974
PMC: PMC230424
OpenAlex: W2113086962
Cited by: 368
References: 46
Citations by year: 2025: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 4 · 2013: 11 · 2012: 3
FWCI: 18.34
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Molecular and Cellular Biology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: American Lebanese Syrian Associated Charities
National Institutes of Health
National Cancer Institute (R01CA064140, P30CA021765)
Topics: Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: ETO, CBFβ, acute myeloid leukemia, transcriptional activation, alternative splicing, DNA-binding domain, nuclear localization, chromosomal translocation
MeSH terms: RUNX1 Translocation Partner 1 Protein, Amino Acid Sequence, Base Sequence, Cell Compartmentation, Cell Nucleus, Cloning, Molecular, DNA-Binding Proteins, Enhancer Elements, Genetic, Gene Expression Regulation, Molecular Sequence Data, Neoplasm Proteins, Protein Binding, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transcription Factors, Transcription, Genetic, Leukemia, Myeloid, Acute, Transcriptional Activation, Consensus Sequence, Alternative Splicing, DNA, Complementary, Core Binding Factors, Core Binding Factor Alpha 2 Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks